Fresenius goes to banks first for $3bn refi of term loan, revolver
German kidney dialysis company Fresenius Medical Care will look to capitalise on what leveraged loan bankers believe is strong demand from banks to refinance its term loan ‘A’ and revolving credit facility.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
